What is INBS's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.00B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for INBS?

P/E (TTM) is n/a and 52-week range is $1.35 to $24.90 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s INBS figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for INBS?

The company profile lists revenue (TTM) near $4M, net income (TTM) near $-1.19B, EPS (TTM) near $-9.66 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Intelligent Bio Solutions Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in New York City, New York, US, 2.4M shares outstanding, ISIN US36151G7097 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Free AI scores & summaries library

Intelligent Bio Solutions Inc

$INBS

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

$1.42

-1.39%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. The company is headquartered in New York City, New York and currently employs 16 full-time employees. The company went IPO on 2020-12-23. The Company’s active product is the Intelligent Fingerprinting Platform, which consists of a portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its Intelligent Fingerprinting Drug Screening System (the IFP System) is a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The IFP System comprises a single-use tamper-evident drug screening cartridge for sample collection and the Intelligent Fingerprinting DSR-Plus portable analysis unit onto which ten fingerprint sweat samples are collected in under a minute before the portable analysis unit provides an on-screen result in under ten minutes.

Employees

Website

ibs.inc/

IPO

2020-12-23

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)